288
Participants
Start Date
October 30, 2023
Primary Completion Date
October 30, 2025
Study Completion Date
December 31, 2025
Anisodine Hydrobromide
Anisodine Hydrobromide 1 mg oral tablet, twice times a day
Anisodine Hydrobromide placebo
Anisodine Hydrobromide Placebo 1 mg oral tablet, twice times a day
NOT_YET_RECRUITING
Medical Community of Linhai First People's Hospital, Linhai
NOT_YET_RECRUITING
People's Hospital Affiliated to Jiangsu University/Zhenjiang First People's Hospital, Zhenjiang
NOT_YET_RECRUITING
Xinhua Hospital of Zhejiang Province, Hangzhou
NOT_YET_RECRUITING
Tongde Hospital of Zhejiang Province, Hangzhou
NOT_YET_RECRUITING
The First People's Hospital of Jiande, Meicheng
NOT_YET_RECRUITING
The First People's Hospital of Huzhou City, Huzhou
NOT_YET_RECRUITING
Tiantai People's Hospital of Zhejiang Province, Tiantai
NOT_YET_RECRUITING
The Second People's Hospital of Yuhuan, Yuhuan
NOT_YET_RECRUITING
Jinhua People's Hospital, Jinhua
NOT_YET_RECRUITING
The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu
NOT_YET_RECRUITING
Dongyang People's Hospital, Dongyang
NOT_YET_RECRUITING
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
NOT_YET_RECRUITING
The Second Affiliated Hospital of Fujian Medical University, Quanzhou
NOT_YET_RECRUITING
Jinjiang Municipal Hospital, Jinjiang
RECRUITING
Kaiming Liu, Hangzhou
NOT_YET_RECRUITING
Guangdong 999 Brain Hospital, Guangzhou
NOT_YET_RECRUITING
Shenzhen People's Hospital, Shenzhen
NOT_YET_RECRUITING
Shenzhen University General Hospital, Shenzhen
NOT_YET_RECRUITING
The First People's Hospital of Zhaoqing, Zhaoqing
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER